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Transcriptional mechanisms involved in the differentiation of the recently identified interleukin-9 (IL-9)
secreting T helper cell subset are still poorly defined. In this issue of Immunity, Staudt et al. (2010) now report
an essential role for the interferon regulatory factor-4 in IL-9 production.Knowledge of CD4+ T helper (Th) cell
biology has expanded rapidly over the
past decade. The discovery of the Th1
cell subset (identified via the production
of interferon-g [IFN-g]), and the Th2
subset (producing interleukin [Il]-4, -5, -6,
and -13), was followed by the identifica-
tion of their respective lineage regulators.
Th1 cell development and IFN-g pro-
duction crucially depend on the T-box
family transcription factor Tbx21, whose
ectopic expression transactivates the
IFN-g locus. Similarly, the GATA-type
zinc finger Gata3 is necessary and suffi-
cient for Th2 cell differentiation and cyto-
kine expression. The prototypic Th1 and
Th2 cell cytokines inhibit each other’s
development, whereas their master regu-
latory genes repress the opposing differ-
entiation program. This suggests a strict
division of labor among the transcription
factors. This view was further strength-
ened when newly discovered subsets
were shown to use unique lineage deter-
mining factors: regulatory T cells (Treg)
using the FOX protein family member
Foxp3 and Th17 cells using the orphan
receptor RORgt. Although a lineage
determining transcription factor for Th9
cells (producing IL-9) has not been identi-
fied, Staudt et al. report an essential role
for the interferon regulatory factor (IRF)-4
in IL-9 expression.
The most important determinants for
lineage commitment are soluble fac-
tors such as cytokines and chemokines,
released by innate immune cells and
stromal cells upon encounter with micro-
organisms or stress. Lineage-specific sig-
nals are largely derived from cytokine
receptor triggering. For example, binding
of cytokines results in activation of partic-
ular signal transducers and activators oftranscription (Stat) proteins, instrumental
in ‘‘master’’ transcription factor induction
(Figure 1). As such, IFN-g induces Th1
cells, IL-4 generates Th2 cells, and the
combination of IL-6 and transforming
growth factor (TGF)-b drives RORgt
expression resulting in Th17 cell develop-
ment. The Th9 subset requires the
concerted action of both IL-4 and TGF-b
(Dardalhon et al., 2008; Veldhoen et al.,
2008).
Gene expression involves numerous
regulatory elements, many of which
require a complex of transcription factors
acting synergistically. The IRF family
members participate in a variety of immu-
nological events, from pathogen recogni-
tion to hematopoietic differentiation and
immune modulation. Their involvement in
such a wide range of processes is reflec-
tive of their capacity to form heterodimers
with each other, as well as with members
of other transcription factor families. The
expression of IRF4 is restricted to the
lymphoid lineage, and it is involved in
various processes including cytokine
signaling and expression, cell prolifera-
tion, and apoptosis. Its deficiency results
in lymphadenopathy, failure to produce
antibodies, and impaired T cell functions.
IRF4 expression in T cells has been shown
to contribute to development of Th2,
Th17, and possibly Th1 cells, and some
particular functions of Treg cells (Bru¨stle
et al., 2007; Lohoff et al., 2002; Zheng
et al., 2009). Comparative expression
analysis of in vitro-generated Th1, Th2,
and Th9 cells revealed the presence of
IRF4 in all three subsets, with highest
expression found in Th9 cells (Staudt
et al., 2010). The importance of IRF4
was established when silencing it in
established Th9 cells resulted in dimin-Immunity 33ished IL-9 production, further corrobo-
rated when IRF4-deficient T cells failed
to produce IL-9. Reporter gene analy-
sis and chromatin immuneprecipitation
(ChIP) assays were able to determine
a direct interaction between IRF4 and
the Il9 promoter, in contrast with an earlier
report, which also reported diminished
IL-9 expression in retroviral-expressing
IRF4-transfected Th2 cells (Ahyi et al.,
2009).
The physiological role of IL-9 is cur-
rently not well defined. Its expression is
found in allergic asthma and its produc-
tion contributes to worm expulsion, but
the role of IL-9 in these processes seems
neither required nor sufficient. However,
studies in IL-9-deficient mice have estab-
lished a role in mast cell proliferation,
pulmonary goblet cell hyperplasia, and
mucusproduction.Staudtet al. useaTcell
adoptive transfer model to establish that
both Th2 and Th9 cell-induced airway
hypersensitivity reactions are very sim-
ilar. However, only the Th9 cell-mediated
disease could be ameliorated via IL-9
neutralization, indicating that a Th9 cell
is a separate and stable subset in vivo,
not reverting back to Th2 cells, but also
confirming the redundancy of IL-9 in
this system. IRF4-deficient cells were
not used in this transfer model; instead,
Irf4/ hosts were challenged and shown
to be resistant to disease, reflecting the
impaired differentiation of both Th2 and
Th9 cells.
The involvement of IRF4 in the devel-
opment of all currently known Th cell
subsets, with the possible exception of
Th1 cells, suggests the function of IRF4
could be upstream of lineage determina-
tion or be reliant on lineage-specific
binding partners. The direct role of IRF4, August 27, 2010 ª2010 Elsevier Inc. 141
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Figure 1. Role and Interactions of IRF4 in T Helper Cell Subsets
IRF4 is expressed in all known Th cell subsets. Its expression, at least in part, can be regulated via signaling strength and duration, STAT proteins, and T helper cell
lineage-specific transcription factors. It is subsequently able to interact with subset-specific binding partners, like Foxp3 (Treg), Bcl6 (Tfh, Th2), and Gata3 and
PU.1 (Th9), among others. The binding partner ultimately determines whether IRF4 acts in an activating or repressing manner. Staudt et al. report the importance
of IRF4 in Il9 gene activation. Earlier reports indicate this may occur when partnered with PU.1.
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the latter (Staudt et al., 2010). Interest-
ingly, in Treg cells, Foxp3 is reported
to induce the expression of IRF4 (Fig-
ure 1), whereas IRF4 deficiency does
not change Foxp3 expression on a per
cell basis. The functional defects in
IRF4-deficient Treg cells are explained
by the presence of composite promoter
elements for the genes encoding Foxp3
and IRF4, as identified in the inducible
costimulator (Icos) gene (Figure 1). Fit-
tingly, a Foxp3-IRF4 protein complex
was indeed identified (Zheng et al.,
2009). This reflects a T cell-intrinsic func-
tion, but its precise role is complex. IRF4
can directly activate the Il4 promoter,
and further stabilizes the Th2 cell pro-
gram by influencing the expression of
Gfi1 (a transcriptional repressor required
for Th2 cell differentiation) and by inter-
acting with Bcl6 (which is a known
repressor of the Th2 cell program). In
Th17 cells, IRF4 deficiency results in
decreased expression of RORgt and
RORa, whereas ectopic expression of
both factors in the absence of IRF4 only
partially rescues Th17 cell differentiation,
reminiscent of Stat3 deficiency (Bru¨stle
et al., 2007). IRF4 was subsequently
shown to be required for IL-21 respon-
siveness, a reported stabilizer of the
Th17 cell transcriptional program sig-
naling via Stat3. In addition, IRF4 is able
to inhibit components of the IL-1R sig-
naling pathway, an important component
for Th17 and Th9 cell activation and func-
tion. A role for IRF4 in yet another
specialized subset of Th, follicular helper
T (Tfh) cells, seems highly likely, consid-142 Immunity 33, August 27, 2010 ª2010 Elsering its involvement in Icos expression,
IL-21 responsiveness, and interaction
with B cell lymphoma (Bcl)-6.
It remains untested whether ectopic
expression of IRF4 would result in the
expression of IL-9 or any other Th cell-
associated cytokines. A recent publica-
tion suggested that PU.1 is required
for IL-9 production as well as allergic
inflammation (Chang et al., 2010), in line
with previous work by the same group
showing heterogeneous expression of
PU.1 in Th2 cells (Chang et al., 2005).
Furthermore, PU.1 was shown to directly
interact with Gata3 (Chang et al.,
2009). Its forced expression is able to
reduce Th2-specific cytokine expression
whereas its inhibition enhances Th2 cyto-
kine production, leaving the expression
of IL-10 unaltered. This is in line with
a proposed linear relationship between
Th2 and Th9 cells in which TGF-b deviates
the Th2 cell cytokine program, inhibiting
Il-4, Il-5, Il-6, and Il-13, toward production
of IL-9 without altering the capacity to
produce IL-10 (Veldhoen et al., 2008).
Interestingly, PU.1 is a known binding
partner of IRF4, forming a ternary com-
plex able to bind immunoglobulin
enhancer elements. PU.1 deficiency was
also shown to impair IL-9 production,
whereas ectopic PU.1 expression in Th2
or Th9 cells enhanced IL-9 production
(Chang et al., 2010). However, the latter
was not established in naive T cells. It
thus remains to be determined whether
either IRF4 or PU.1 is able to enforce the
Th9 cell transcriptional program in naive
T cells (Chang et al., 2010; Staudt et al.,
2010).evier Inc.The expression of specific transcrip-
tion factors is secondary to T cell receptor
(TCR) activation and expansion. This
is instigated upon naive T cell recogni-
tion of cognate antigen presented by
antigen-presenting cells (APCs). Impor-
tantly, it takes place in context of
additional signals, like costimulatory
receptors, ultimately triggering several
common signal transduction cascades.
The combination as well as the strength
and duration of these signals culminate
in translocation of several factors to the
nucleus, regulating the expression of
genes permissive for proliferation and
differentiation. Key determinants in this
process are nuclear factor kappa-light-
chain-enhancer of activated B cells
(NF-kB), activator protein 1 (AP-1), and
nuclear factor of activated T cells (NFAT)
proteins. A major determinant of IRF4
expression is the strength of TCR stimula-
tion, involving NF-kB family members.
In addition, expression of PU.1 is also
associated with increased strength of
TCR stimulation, correlating with IL-10
production.
This suggests that the earlier reported
heterogeneity within Th2 cell populations
may reflect established Th2 cells that
have received varying degrees of TCR
stimulation. Increased TCR signals via
NF-kB and NFAT, the latter a known
binding partner of IRF4, may enhance
the expression of both IRF4 and PU.1.
Additional T cell stimulation, such as
with IL-2, IL-25, and IL-1b, may also
contribute to increased expression of
IRF4 and PU.1. Current results thus
seem indicative of Th2 cell ancestry for
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mining events, Stat6 signaling and
Gata3 expression, seem a developmental
requirement for Th9 cells. The combina-
tional expression of both IRF4 and PU.1
could thus be instrumental in (re)program-
ming classical Th2, inhibiting IL-4, IL-5,
IL-6, and IL-13 and inducing IL-9 while
maintaining IL-10 (Figure 1).
The abundance of IRF4 interacting
partners, determining its DNA binding
interactions and its functioning as either
a transcriptional activator or repressor,
suggests that its interactions in different
cell types and its level of expression may
be more important than the presence of
IRF4 in itself.REFERENCES
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The endogenous lipids that control the functions of invariant natural killer T (iNKT) cells remain enigmatic.
In this issue of Immunity, Darmoise et al. (2010) report that lysosomal a-galactosidase A destroys self-anti-
gens recognized by iNKT cells.Autoreactivity in the adaptive immune
system is normally curtailed by rigorous
selection processes in central lymphoid
organs, followed by tolerance mecha-
nisms in the periphery. However, some
populations of lymphocytes appear to
require at least some level of autoreactiv-
ity in order to effectively dispatch their
effector functions. These cells largely
carry out functions related to the detec-
tion of self-ligands that are induced in
injured or stressed tissues. Invariant
natural killer T (iNKT) cells belong to this
family of innate lymphocytes that exhibit
natural autoreactivity. iNKT cells are
specific for lipid antigens bound by the
MHC class I-related protein CD1d. These
cells express a semi-invariant T cell
receptor (TCR) (Va14-Ja18 in mice or
Va24-Ja18 in humans) together with
lineage markers of natural killer (NK) cells.Following TCR engagement, iNKT cells
rapidly elicit their effector functions to
generate protective immunity against
pathogens and tumors and to suppress
autoimmunity. Several foreign lipid anti-
gens that can activate iNKT cells have
been identified, including the marine
sponge-derived glycosphingolipid a-gal-
actosylceramide that is commonly em-
ployed to study iNKT cells. However, the
natural self-antigens that mediate iNKT
cell autoreactivity remain enigmatic, and
their identity is hotly debated (Gapin,
2010). A provocative study by Darmoise
et al. (2010) in this issue of Immunity
provides evidence that the lysosomal
enzyme a-galactosidase A (a-Gal-A)
controls the generation of self-antigens
for iNKT cells.
The hunt for natural iNKT cell antigens
has taken several twists and turns. Aninitial study with a cell line deficient in
b-glucosylceramide synthase pointed
toward glycosphingolipids as natural
ligands of iNKT cells (Stanic et al., 2003).
A subsequent study demonstrated
defective iNKT cell development in mice
lacking the b-hexosaminidase A and B
(b-Hex-AB) enzymes, which participate
in the degradation of glycosphingolipids
in lysosomes (Zhou et al., 2004). Isoglobo-
trihexosylceramide (iGb3) was identified
as a natural self-antigen by investigating
the capacity of various products of this
pathway to activate iNKT cells. However,
subsequent studies cast doubt on iGb3
as the sole endogenous antigen respon-
sible for iNKT cell development because
conventional biochemical and mass
spectrometry techniques were unable to
identify iGb3 in lymphoid tissues, mice
deficient in iGb3 synthase exhibited, August 27, 2010 ª2010 Elsevier Inc. 143
